205 related articles for article (PubMed ID: 20696839)
1. Cell-type-specific activation and repression of PU.1 by a complex of discrete, functionally specialized cis-regulatory elements.
Zarnegar MA; Chen J; Rothenberg EV
Mol Cell Biol; 2010 Oct; 30(20):4922-39. PubMed ID: 20696839
[TBL] [Abstract][Full Text] [Related]
2. PU.1 is a major downstream target of AML1 (RUNX1) in adult mouse hematopoiesis.
Huang G; Zhang P; Hirai H; Elf S; Yan X; Chen Z; Koschmieder S; Okuno Y; Dayaram T; Growney JD; Shivdasani RA; Gilliland DG; Speck NA; Nimer SD; Tenen DG
Nat Genet; 2008 Jan; 40(1):51-60. PubMed ID: 17994017
[TBL] [Abstract][Full Text] [Related]
3. Runx1 promotes murine erythroid progenitor proliferation and inhibits differentiation by preventing Pu.1 downregulation.
Willcockson MA; Taylor SJ; Ghosh S; Healton SE; Wheat JC; Wilson TJ; Steidl U; Skoultchi AI
Proc Natl Acad Sci U S A; 2019 Sep; 116(36):17841-17847. PubMed ID: 31431533
[TBL] [Abstract][Full Text] [Related]
4. The Pu.1 locus is differentially regulated at the level of chromatin structure and noncoding transcription by alternate mechanisms at distinct developmental stages of hematopoiesis.
Hoogenkamp M; Krysinska H; Ingram R; Huang G; Barlow R; Clarke D; Ebralidze A; Zhang P; Tagoh H; Cockerill PN; Tenen DG; Bonifer C
Mol Cell Biol; 2007 Nov; 27(21):7425-38. PubMed ID: 17785440
[TBL] [Abstract][Full Text] [Related]
5. Stage-specific action of Runx1 and GATA3 controls silencing of PU.1 expression in mouse pro-T cells.
Hosokawa H; Koizumi M; Masuhara K; Romero-Wolf M; Tanaka T; Nakayama T; Rothenberg EV
J Exp Med; 2021 Aug; 218(8):. PubMed ID: 34180951
[TBL] [Abstract][Full Text] [Related]
6. Ikaros represses and activates PU.1 cell-type-specifically through the multifunctional Sfpi1 URE and a myeloid specific enhancer.
Zarnegar MA; Rothenberg EV
Oncogene; 2012 Oct; 31(43):4647-54. PubMed ID: 22231443
[TBL] [Abstract][Full Text] [Related]
7. Lymphoid cell growth and transformation are suppressed by a key regulatory element of the gene encoding PU.1.
Rosenbauer F; Owens BM; Yu L; Tumang JR; Steidl U; Kutok JL; Clayton LK; Wagner K; Scheller M; Iwasaki H; Liu C; Hackanson B; Akashi K; Leutz A; Rothstein TL; Plass C; Tenen DG
Nat Genet; 2006 Jan; 38(1):27-37. PubMed ID: 16311598
[TBL] [Abstract][Full Text] [Related]
8. The +37 kb Cebpa Enhancer Is Critical for Cebpa Myeloid Gene Expression and Contains Functional Sites that Bind SCL, GATA2, C/EBPα, PU.1, and Additional Ets Factors.
Cooper S; Guo H; Friedman AD
PLoS One; 2015; 10(5):e0126385. PubMed ID: 25938608
[TBL] [Abstract][Full Text] [Related]
9. PU.1 is regulated by NF-kappaB through a novel binding site in a 17 kb upstream enhancer element.
Bonadies N; Neururer Ch; Steege A; Vallabhapurapu S; Pabst T; Mueller BU
Oncogene; 2010 Feb; 29(7):1062-72. PubMed ID: 19966852
[TBL] [Abstract][Full Text] [Related]
10. Runx1 regulation of Pu.1 corepressor/coactivator exchange identifies specific molecular targets for leukemia differentiation therapy.
Gu X; Hu Z; Ebrahem Q; Crabb JS; Mahfouz RZ; Radivoyevitch T; Crabb JW; Saunthararajah Y
J Biol Chem; 2014 May; 289(21):14881-95. PubMed ID: 24695740
[TBL] [Abstract][Full Text] [Related]
11. Subnuclear targeting of Runx1 is required for synergistic activation of the myeloid specific M-CSF receptor promoter by PU.1.
Li X; Vradii D; Gutierrez S; Lian JB; van Wijnen AJ; Stein JL; Stein GS; Javed A
J Cell Biochem; 2005 Nov; 96(4):795-809. PubMed ID: 16149049
[TBL] [Abstract][Full Text] [Related]
12. Structurally differentiated cis-elements that interact with PU.1 are functionally distinguishable in acute promyelocytic leukemia.
Qian M; Jin W; Zhu X; Jia X; Yang X; Du Y; Wang K; Zhang J
J Hematol Oncol; 2013 Apr; 6():25. PubMed ID: 23547873
[TBL] [Abstract][Full Text] [Related]
13. PU.1 is a lineage-specific regulator of tyrosine phosphatase CD45.
Anderson KL; Nelson SL; Perkin HB; Smith KA; Klemsz MJ; Torbett BE
J Biol Chem; 2001 Mar; 276(10):7637-42. PubMed ID: 11114304
[TBL] [Abstract][Full Text] [Related]
14. PU.1 binding to ets motifs within the equine infectious anemia virus long terminal repeat (LTR) enhancer: regulation of LTR activity and virus replication in macrophages.
Hines R; Sorensen BR; Shea MA; Maury W
J Virol; 2004 Apr; 78(7):3407-18. PubMed ID: 15016863
[TBL] [Abstract][Full Text] [Related]
15. Potential autoregulation of transcription factor PU.1 by an upstream regulatory element.
Okuno Y; Huang G; Rosenbauer F; Evans EK; Radomska HS; Iwasaki H; Akashi K; Moreau-Gachelin F; Li Y; Zhang P; Göttgens B; Tenen DG
Mol Cell Biol; 2005 Apr; 25(7):2832-45. PubMed ID: 15767686
[TBL] [Abstract][Full Text] [Related]
16. GATA-1 Inhibits PU.1 Gene via DNA and Histone H3K9 Methylation of Its Distal Enhancer in Erythroleukemia.
Burda P; Vargova J; Curik N; Salek C; Papadopoulos GL; Strouboulis J; Stopka T
PLoS One; 2016; 11(3):e0152234. PubMed ID: 27010793
[TBL] [Abstract][Full Text] [Related]
17. Expression of two myeloid cell-specific genes requires the novel transcription factor, c-fes expression factor.
Heydemann A; Boehmler JH; Simon MC
J Biol Chem; 1997 Nov; 272(47):29527-37. PubMed ID: 9368014
[TBL] [Abstract][Full Text] [Related]
18. Regulation of early T-lineage gene expression and developmental progression by the progenitor cell transcription factor PU.1.
Champhekar A; Damle SS; Freedman G; Carotta S; Nutt SL; Rothenberg EV
Genes Dev; 2015 Apr; 29(8):832-48. PubMed ID: 25846797
[TBL] [Abstract][Full Text] [Related]
19. C/EBPalpha binds and activates the PU.1 distal enhancer to induce monocyte lineage commitment.
Yeamans C; Wang D; Paz-Priel I; Torbett BE; Tenen DG; Friedman AD
Blood; 2007 Nov; 110(9):3136-42. PubMed ID: 17671233
[TBL] [Abstract][Full Text] [Related]
20. RUNX1 regulates corepressor interactions of PU.1.
Hu Z; Gu X; Baraoidan K; Ibanez V; Sharma A; Kadkol S; Munker R; Ackerman S; Nucifora G; Saunthararajah Y
Blood; 2011 Jun; 117(24):6498-508. PubMed ID: 21518930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
